GENTAMICIN SULFATE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has issued award SPE2DP22F6214 to DMS Pharmaceutical Group Inc for the procurement of Gentamicin Sulfate. This contract, identified by NSN/Part 6505012139514, was awarded on August 24, 2026, as a delivery order under the primary contract SPE2DX15D9383. The agreement is managed by the Department of Defense and is categorized as a federal organization award. While the total contract price is specified within the award documentation, the primary objective of the order is the supply of the designated pharmaceutical item to the agency.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
